The genetics of chronic headaches

Neurological Sciences

Volumn 24, Issue SUPPL. 2, 2003, Pages

  Montagna, P ^a   Cevoli, S ^a   Marzocchi, N ^b   Pierangeli, G ^a   Pini, L A ^b   Cortelli, P ^a   Mochi, M ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

Chronic headache; Dopamine; Drug abuse; Genetics; Migraine; Serotonin; Tension headache

Indexed keywords

AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME A; ANALGESIC AGENT; CATECHOL METHYLTRANSFERASE; DIPEPTIDYL CARBOXYPEPTIDASE; DOPAMINE 2 RECEPTOR; DOPAMINE 4 RECEPTOR; DOPAMINE TRANSPORTER;

ALLELE; ANXIETY; CHRONIC PAIN; COMORBIDITY; DRUG ABUSE; GENE LOCUS; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETIC RISK; GENETIC VARIABILITY; HEADACHE; HUMAN; MAJOR DEPRESSION; METABOLIC ACTIVATION; MIGRAINE; MOLECULAR GENETICS; PATHOGENESIS; RELATIVE; REVIEW; SUBSTANCE ABUSE; TENSION HEADACHE;

EID: 0037977035     PISSN: 15901874     EISSN: None     Source Type: Journal    
DOI: 10.1007/s100720300041     Document Type: Review

References (57)

1. Mathew NT (1993) Transformed migraine. Cephalalgia 13[Suppl 12]:78-83
2. Sher AI, Stewart WF, Libermann J et al (1988) Prevalence of frequent headache in a population sample. Headache 38:497-506
3. Castillo J, Munoz P, Guitera V, Pascual J (1999) Epidemiology of chronic daily headache in the general population. Headache 39:190-196
4. Diaz-Insa S, Lainez MJ, Lazzaro C (2001) Chronic daily headache with drug abuse. Prevalence in a population attending a general health center. Cephalalgia 21:466
5. Saper J (1990) Daily chronic headache. Neurol Clin 8:891-901
6. Saper J (1988) Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Headache Classification Committee of the International Headache Society. Cephalalgia 8:1-96
7. Diener HC, Katasarva Z (2001) Analgesic/abortive overuse and misuse in chronic daily headache. Curr Pain Headache Rep 5:545-550
8. Jensen R, Olesen J (1996) Initiating mechanisms of experimentally induced tension type headache. Cephalalgia 16:175-182
9. Bendsten L, Ashina M (2000) Sensitization of myofascial pain pathways in tension type headache. In: Olesen J et al (eds) The headaches, 2nd edn. Lippincott, Williams and Wilkins, Philadelphia, pp 573-577
10. Welch KMA, Goadsby PJ (2002) Chronic daily headache: nosology and pathophysiology. Curr Opin Neurol 15:287-295
11. Ozturk V, Cakmur R, Donmez B, Yener GG, Kursad F, Idiman F (2002) Comparison of cortical excitability in chronic migraine (transformed migraine) and migraine without aura. A transcranial magnetic stimulation study. J Neurol 249:1268-1271
12. Welch KMA, Nagesh V, Aurora S, Gelman N (2001) Periaqueductal grey matter dysfunction in migraine: cause or the burden of illness? Headache 41:629-637
13. Robbins TW, Everett BJ (1999) Drug addiction: bad habits add up. Nature 398:567-570
14. Price-Evans DA (1993) Genetic factors in drug therapy. Cambridge University, Cambridge
15. Gardner EL (1992) Brain reward mechanisms. In: Lowinston SH et al (eds) Substance abuse: a comprehensive textbook, 2nd edn. Williams and Wilkins, Baltimore, pp 70-99
16. Hyman SE, Malenka RC (2001) Addiction and the brain: the neurobiology of compulsion and its persistence. Nature Neurosci 2:695-703
17. Koob GF, Bloom FE (1988) Cellular and molecular mechanisms of drug dependence. Science 242:715-723
18. Vandenbergh DJ, Rodriguez LA, Miller IT, Uhl GR, Lachman HM (1997) High-activity catecol-O-methyl transferase allele is more prevalent in polysubstance abusers. Am J Med Genet 74:439-442
19. Zubieta JK, Heitzeg MH, Smith YR, Bueller JA, Xu K, Xu Y, Koeppe RA, Stohler CS, Goldman D (2003) COMT val 158 met genotype affects μ-opioid neurotransmitter responses to a pain stressor. Science 299:1240-1243
20. George SR, Cheng R, Nguyen T, Israel Y, O'Dowd BF (1993) Polymorphisms of the D4 dopamine receptor alleles in chronic alcoholism. Biochem Biophys Res Comm 196:107-114
21. Benjamin J, Li L, Patterson G, Geenberg BD, Murphy DL, Hamer DH (1996) Population and familial association between the D4 receptor gene and measures of novelty seeking. Nat Genet 12:81-84
22. Ebstein EP, Novick O, Umansky R, Priel B, Osher Y, Blaine D, Bennett ER, Nemanov L, Katz M, Belmaker RH (1996) Dopamine D4 receptor (D4DR) exon III polymorphism associated with the human personality trait of novelty seeking. Nat Genet 12:78-80
23. Kotler M, Cohen H, Segman R, Gritsenko I, Nemanov L, Lerer B, Kramer I, Zer-Zion M, Kletz I, Ebstein RP (1997) Excess dopamine D4 receptor (DRD4) exon III seven repeat allele in opioid-dependent subjects. Mol Psychiat 2:251-254
24. Vandenbergh DJ, Rodriguez LA, Hivert E, Shiller JH, Villareal G, Pugh EW, Lachman H, Uhl GR (2000) Long forms of the dopamine receptor (DRD4) gene VNTR are more prevalent in substance abusers: no interaction with functional alleles of the catechol-O-methyltransferase (COMT) gene. Am J Med Genet 96:678-683
25. Schinka J, Letsch EA, Crawford FC (2002) DRD4 and novelty seeking: results of meta-analyses. Am J Med Genet 114:643-648
26. Gelernter J, Kranzler H, Coccaro E, Siever L, New A, Mulgrew CL (1997) D4 dopamine receptor (DRD4) alleles and novelty seeking in substance-dependent, personality disorder and control subjects. Am J Hum Genet 61:1144-1152
27. Lerman C, Caporaso NE, Audrain J, Main D, Bowman ED, Lockshin B, Boyd NR, Shields PG (1999) Evidence suggesting the role of specific genetic factors in cigarette smoking. Health Psychol 18:14-20
28. Sabol SZ, Nelson ML, Fisher C, Gunzerath L, Brody CL, Hu S, Sirota LA, Marcus SE, Greenberg BD, Lucas FR, Benjamin J, Murphy DL, Hamer DH (1999) A genetic association for cigarette smoking behaviour. Health Psychol 18:7-13
29. Saito T, Lachman HM, Duaz L, Hallikainene T, Kauhanen J, Salomen JT, Ryynaneh OP, Karvonen MK, Syvalahti E, Pohjalainen T, Hietala J, Tiihonen J (2002) Analysis of monoamino oxidase A (MAOA) promoter polymorphism in Finnish male alcoholics. Psychiatry Res 109:113-119
30. Bigal ME, Sheftell FD, Rapoport AM, Tepper SJ, Lipton RB (2002) Chronic daily headache: identification of factors associated with induction and transformation. Headache 42:575-581
31. Wiehe M, Costa Fuchs S, Moreira LB, Stoll Moraes R, Fuchs FD (2002) Migraine is more frequent in individuals with optimal and normal blood pressure: a population-based study. J Hypertens 20:1303-1306
32. Nylander PO, Schlette P, Brandstrom S, Nilsson M, Forsgren T, Forsgren L, Adolfsson R (1996) Migraine: temperament and character. J Psychiatr Res 30:359-368
33. Magnusson JE, Becker WJ (2002) A comparison of disability and psychological factors in migraine and transformed migraine. Cephalalgia 22:172-178
34. Sarchielli P, Alberti A, Floridi A, Gallai V (2002) L-Arginine/nitric oxide pathway in chronic tension-type headache: relation with serotonin content and secretion and glutamate content. J Neurol Sci 198:9-15
35. Srikiatkhachorn A, Maneesri S, Govitrapong P, Kasantikul V (1998) Derangement of serotonin system in migraineous patients with analgesic abuse headache: clues from platelets. Headache 38:43-49
36. Srikiatkhachorn A, Tarasub N, Govitrapong P (2000) Effect of chronic analgesic exposure on the central serotonin system: a possible mechanism of analgesic abuse headache. Headache 40:343-350
37. Cassidy EM, Tomkins E, Sharifi N, Dinan T, Hardiman O, O'Keane V (2003) Differing central amine receptor sensitivity in different migraine subtypes? A neuroendocrine study using buspirone. Pain 101:283-290
38. Friederichs H, Olesen J, Russell MB (1999) Familiar occurrence of chronic tension headache. Ugeskr Laeger 161:576-578
39. Russell MB, Ostergaard S, Bendtsen L, Olesen J (1999) Familial occurrence of chronic tension-type headache. Cephalalgia 19:207-210
40. Ostergaard S, Russell MB, Bendtsen L, Olesen J (1997) Comparison of first degree relatives and spouses of people with chronic tension headache. Br Med J 314:1092-1093
41. Russell MB, Iselius L, Ostergaard S, Olesen J (1998) Inheritance of chronic tension-type headache investigated by complex segregation analysis. Hum Genet 102:138-140
42. Russell MB, Hilden J, Sorensen SA, Olesen J (1993) Familial occurrence of migraine without aura and migraine with aura. Neurology 43:1369-1373
43. Russell MB, Iselius L, Olesen J (1996) Migraine without aura and migraine with aura are inherited disorders. Cephalalgia 16:305-309
44. Nyholt DR, Curtain RP, Griffiths LR (2000) Familial typical migraine: significant linkage and localization of a gene to Xq24-28. Hum Genet 107:18-23
45. Soragna D, Vettori A, Carraro G, Marchioni E, Vazza G, Bellini S, Tupler R, Savoldi F, Mostacciuolo ML (2003) A locus for migraine without aura maps on chromosome 14q21.2-q22.3. Am J Hum Genet 72:161-167
46. Wessman M, Kallela M, Kaunisto MA, Marttila P, Sobel E, Hartiala J, Oswell G, Leal SM, Papp JC, Hamalainen E, Broas P, Joslyn G, Hovatta I, Hiekkalinna T, Kaprio J, Ott J, Kantor RM, Zwart JA, Ilmavirta M, Havanka H, Farkila M, Peltonen L, Palotie A (2002) A susceptibility locus for migraine with aura on chromosome 4q24. Am J Hum Genet 70:652-662
47. Kaiser F (2002) Anticipation in migraine with affective psychosis. Am J Med Genet 110:62-64
48. Fukutake T, Sakakibara R, Mori M, Araki M, Hattori T (1997) Chronic intractable headache in a patient with Marfan's syndrome. Headache 37:291-295
49. Peroutka SJ, Price SC, Wilhoit TL, Jones KW (1998) Comorbid migraine with aura, anxiety, and depression is associated with dopamine D2 receptor (DRD2) NcoI alleles. Mol Med 4:14-21
50. Dichgans M, Forderreuther S, Deiterich M, Pfaffenrath V, Gasser T (1998) The D2 receptor NcoI allele: absence of allelic association with migraine with aura. Neurology 51:928
51. Mochi M, Monari L, Valentino ML, Cevoli S, Cortelli P, Pierangeli G, Soriani S, Montagna P (2000) Migraine and dopamine metabolism related genes: a genetic association study. Cephalalgia 20:266
52. Lea RA, Dohy A, Jordan K, Quinlan S, Brimage PJ, Griffiths LR (2000) Evidence for allelic association of the dopamine beta-hydroxylase gene (DBH) with susceptibility to typical migraine. Neurogenetics 3:35-40
53. Maude S, Curtin J, Breen G, Collier D, Russell G, Shaw D, Clair DS (2001) The 141C Ins/Del polymorphism of the dopamine D2 receptor gene is not associated with either migraine or Parkinson's disease. Psychiatr Genet 11:49-52
54. Shepherd AG, Lea RA, Hutchins C, Jordan KL, Brimage PJ, Griffiths LR (2002) Dopamine receptor genes and migraine with and without aura: an association study. Headache 42:346-351
55. Paterna S, Di Pasquale P, D'Angelo A, Seidita G, Tuttolomondo A, Cardinale A, Maniscalchi T, Follone G, Giubilato A, Tarantello M, Licata G (2000) Angiotensin-converting enzyme gene deletion polymorphism determines an increase in frequency of migraine attacks in patients suffering from migraine without aura. Eur Neurol 43:133-136
56. Cevoli S, Mochi M, Cortelli P, Pierangeli G, Marzocchi N, Pini LA, Montagna P (2003) A genetic association study of chronic daily headache (CDH) with drug overuse with the dopamine receptor 4 (DRD4), dopamine transporter (DAT), monoamino oxidase A (MAOA) and catechol-O-methyltransferase (COMT) genes. In: 55th Annual Meeting of the American Academy of Neurology, Honolulu, 29 March-5 April 2003 (abstract)
57. Silberstein SD, Peres MF, Hopkins MM, Shechter AL, Young WB, Rozen TD (2002) Olanzapine in the treatment of refractory migraine and chronic daily headache. Headache 42:515-518